Call for submissions: ASCI member host labs, 2025–2027

As part of the ASCI’s Postbac Program, the ASCI is pleased to call for submissions from Society members who are interested in their labs serving as hosts for Program finalists for 2025–2027.

Any member can provide a submission by:

The deadline for submissions is March 3, 2025, 11:59 pm Eastern.

Submissions consist of the following sections:

  • Your information
    • Your institution
    • Your trainee table (PDF upload)
  • About your lab
    • Lab website
    • Lab description and environment (500-word limit). Provide detail on mentoring awards, motivation for applying, and mentorship plan (what presentation will be expected, feedback provided, and participation).
    • Lab member who would be assigned for day-to-day mentoring of the postbac (name, position)
    • Assignee’s biosketch (PDF upload)
  • Institutional resources
    • Provide detail on aspects such as the requisite amount of bench/desk space in lab, faculty member to work with the student on medical-school essay, institutional career development, and educational and networking opportunities.
    • Institutional stipend levels. The ASCI expects stipends to fall within the ranges of the NIH post-bac IRTA program, with the understanding that the cost of living ranges widely depending on location. Provide information for 2025–2026 and 2026–2027.
    • Indicate if you are able to supplement beyond your institution’s stipend amounts or beyond the ASCI’s maximum grant of $55,000 ($50,000 direct; $5,000 indirect).

Nominations for ASCI Council, 2025

  • Access your member account
  • Go to the “Nominations” tab
  • In the section for “Council vacancies”:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

    The Society seeks nominations for the following ASCI Council vacancies arising in 2025 (all terms begin and end in the spring):

    • Vice President (4-year term, 2025-2029)
    • Councilor (2 positions, 3-year term, 2025-2028)

    Those eligible for nomination must be in the Active category and:

    • for Vice President, do not turn 56 until 2030 or later
    • for Councilor, do not turn 56 until 2029 or later

    The Society strongly encourages members to consider diversity in identifying those suitable for nomination. Self-nominations are not permitted. Nominations may be submitted by any member in good standing (with dues up to date if applicable) and must be submitted by February 17, 2025, at 11:59 PM EST.

    All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, with the spring meeting occurring as part of the annual meeting) and videoconference calls (typically every other month). All Council members participate in the review of membership and various award nominations and subsequent discussion at the fall meeting.

    The Vice President transitions to President-Elect in year 2, President in year 3, and Immediate Past President in year 4. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the annual meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program and presents the traditional Presidential Address at the meeting.

    The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council. For details on Officers and Councilors, see the ASCI Bylaws.

    Nominators:

    • may be any ASCI member
    • must provide a statement (250-word limit) regarding the nominee

    Nominees:

    • must specify the position of interest (Vice President, Councilor);
    • provide a 250-word candidate statement, written in first person, for consideration by the Council and for use as the ballot statement if the nominee is selected as a candidate (nominees may refer to candidate statements for the 2024 nomination cycle for guidance in drafting their own statements);
    • provide an NIH-style biosketch;
    • must complete the ASCI’s demographic survey and provide information about research domain(s).

    To start a nomination:

    • Access your member account
    • Go to the “Nominations” tab
    • In the section for “Council vacancies”:
      • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
      • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

    Update from the JCI Insight Editor

    Dr. Eickelberg

    Allow me to introduce some of the initiatives our University of Pittsburgh team has implemented over the past several months after onboarding as the new Editorial Board for JCI Insight. The overarching aim for the University of Pittsburgh editorial team is to make publishing cutting-edge research and reviews easier, speedier, and less labor-intensive for our authors. At the same time, we intend to serve our constituency by publishing excellent and exciting science. Here are some of the new and upcoming efforts that our Board is undertaking.

    1. JCI Insight now publishes Research Letters. These short reports feature content with highly novel and impactful disease-relevant findings that may not have fully explored mechanistic insights expected from a full-length article. We trust that this new category will particularly appeal to our early-stage career faculty, such as K awardees or equivalents, as well as ASCI Emerging-Generation (E-Gen) Award and Young Physician-Scientist Award (YPSA) recipients.
    2. We are pleased to support early-stage investigators by including YPSA/E-Gen Award recipients as associate editors. The integration of early-stage career faculty into the editorial team of JCI Insight will grow their skill set, academic profile, and integration into the ASCI.
    3. We are very excited to feature our JCI–JCI Insight Dual-Journal Submission process, in partnership with the Journal of Clinical Investigation. Papers designated for the Dual-Journal Submission track will automatically be considered by JCI Insight in the event that the JCI rejects the manuscript, saving our authors and reviewers valuable time and allowing quick identification of the journal that is the best fit.
    4. We encourage authors to upload reviews from other journals with their submissions. The goal of this program is to streamline the review process, particularly when authors have completed revisions in response to prior peer reviews. The Editors will consider this information along with the manuscript in determining a priority fit for JCI Insight.
    5. Look for enhanced coverage of articles and author stories on social media. We will feature content on XBlueSkyLinkedInFacebook, and Instagram, so please tag us in your conversations about your work.

    In addition, we are planning several other activities in the coming year. We will publish themed issues highlighting biological mechanisms that drive disease. Look for a call for papers in the coming month for our first themed issue, “Mechanisms of fibrosis across tissues.” Our team will also add monthly “office hours” to allow authors to discuss submissions with the editorial team, to facilitate the review process, and to manage expectations for potential revisions.

    Finally, we have one very ambitious goal: Rapid Launch publications. Our editors plan to select a few submissions this year for expedited review and publication by JCI Insight, with a provisional acceptance decision within 15 days after submission. We hope that our authors will appreciate the competitive advantage of publishing in JCI Insight on highly novel and significant topics, without compromising on the quality of expert peer review. If you feel that your lab has exciting work that would be suitable for this track, we encourage you to contact us at editors@insight.jci.org.

    Best regards,

    Oliver Eickelberg, MD
    Editor in Chief
    JCI Insight
    https://insight.jci.org

    P.S. See publications in the last 3 months by ASCI-member corresponding authors:
    https://the-asci.org/controllers/asci/Journals.php?#jci-insight

    Announcing the ASCI’s 2025 Early-Career Awardees

    The American Society for Clinical Investigation is proud to announce our 2025 Early-Career Awardees:

    Young Physician-Scientist Awards

    The ASCI Young Physician-Scientist Awards recognize physician-scientists who are early in their first faculty appointment and have made notable achievements in their research. Our 50 Young Physician-Scientist Awardees (see all awardees) were drawn from an exceedingly talented group of 188 nominees.

    Emerging-Generation Awards

    The ASCI Emerging-Generation Awards recognize post-MD, pre-faculty appointment physician-scientists who are meaningfully engaged in immersive research. Our 26 Emerging-Generation Awardees (see all awardees) were drawn from an equally talented group of 98 nominees.

    With these awards, the ASCI seeks to encourage and inspire these physician-scientists through their participation in the AAP/ASCI/APSA Joint Meeting and through access to and participation in the ASCI community. These awards provide a two-year longitudinal experience that includes:

    • leadership development workshops
    • topical panel discussions with distinguished ASCI members
    • scientific and career-oriented networking and mentorship opportunities

    Congratulations to our awardees and to the institutions they represent!

    Please direct any questions to programs@the-asci.org.

    The ASCI’s 2025 Active and International elected members

    The ASCI is pleased to announce the election of 99 Active and International members for 2025.

    These new members come from 46 different institutions and represent excellence across the breadth of academic medicine. They will be officially inducted into the Society at the ASCI Dinner and New Member Induction Ceremony, April 25, 2025, as part of the AAP/ASCI/APSA Joint Meeting, April 25–27, at the Swissotel Chicago.

    Active and International members, 2025

    Daniel Addison, MD
    Ohio State University College of Medicine
    Sally Nneoma Sarah Adebamowo, MBBS, MSc, ScD
    University of Maryland School of Medicine
    Manmeet Singh Ahluwalia, MD, MBA
    Florida International University
    Niroshana Anandasabapathy, MD, PhD
    Weill Cornell Medicine
    Jason Randolph Andrews, MD
    Stanford University School of Medicine
    Saro H. Armenian, DO, MPH
    City of Hope Medical Center
    Pratiti Bandopadhayay, MBBS, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Alexander G. Bick, MD, PhD
    Vanderbilt University Medical Center
    Ranjit S. Bindra, MD, PhD
    Yale School of Medicine
    Eli A. Boritz, MD, PhD
    NIH, National Institute of Allergy and Infectious Diseases (NIAID)
    David A. Braun, MD, PhD
    Yale School of Medicine
    Joshua D. Brody, MD
    Icahn School of Medicine at Mount Sinai
    Cesar Martin Castro, MD, MS, MMSc
    Harvard Medical School, Massachusetts General Hospital
    Andrea Cercek, MD
    Memorial Sloan Kettering Cancer Center
    Rohit Chandwani, MD, PhD
    Weill Cornell Medicine
    Daniel I-Hsin Chu, MD, MSPH, FACS, FASCRS
    University of Alabama at Birmingham School of Medicine
    Nicole G. Coufal, MD, PhD
    University of California, San Diego, School of Medicine
    Mucio Kit Delgado, MD, MS
    University of Pennsylvania Perelman School of Medicine
    Rajat Deo, MD, MTR
    University of Pennsylvania Perelman School of Medicine
    Jörg Hans Wilhelm Distler, MD
    Heinrich-Heine-University Duesseldorf
    Michael Thomas Eadon, MD
    Indiana University School of Medicine
    Yi Fan, MD, PhD
    University of Pennsylvania Perelman School of Medicine
    Mariella G. Filbin, MD, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Terence Peter Gade, MD, PhD
    University of Pennsylvania Perelman School of Medicine
    Ethan M. Goldberg, MD, PhD
    Children’s Hospital of Philadelphia
    Misty Good, MD, MS
    University of North Carolina School of Medicine
    Madhusudan Grover, MBBS
    Mayo Clinic
    Rajat M. Gupta, MD
    Harvard Medical School, Brigham & Women’s Hospital
    Lida P. Hariri, MD, PhD
    Harvard Medical School, Massachusetts General Hospital
    Takashi Hato, MD
    Indiana University School of Medicine
    Jorge Henao-Mejia, MD, PhD
    University of Pennsylvania Perelman School of Medicine
    Angela Christine Hirbe, MD, PhD
    Washington University School of Medicine in St. Louis
    Lori Rachel Holtz, MD, MSPH
    Washington University School of Medicine in St. Louis
    William Tzu-lung Hu, MD, PhD, FAAN
    Rutgers, Robert Wood Johnson Medical School
    Alison Ju-Tsu Huang, MD, MAS
    University of California, San Francisco, School of Medicine
    Jason T. Huse, MD, PhD
    University of Texas MD Anderson Cancer Center
    Tamara Isakova, MD, MMSc
    Northwestern University Feinberg School of Medicine
    Prasanna Jagannathan, MD
    Stanford University School of Medicine
    Tobias Janowitz, MBBChir, PhD
    Cold Spring Harbor Laboratory
    Robert R. Jenq, MD
    City of Hope Medical Center
    Wen Jiang, MD, PhD
    University of Texas MD Anderson Cancer Center
    Sadiya Sana Khan, MD, MSc
    Northwestern University Feinberg School of Medicine
    John B. Kisiel, MD, MS
    Mayo Clinic
    Jeffery M. Klco, MD, PhD
    St. Jude Children’s Research Hospital
    Liza (Yelizaveta) Konnikova, MD, PhD
    Yale School of Medicine
    Jonathan Andrew Kropski, MD
    Vanderbilt University School of Medicine
    Hrishikesh S. Kulkarni, MD, MSCI
    University of California, Los Angeles, David Geffen School of Medicine
    Sonia S. Kupfer, MD
    University of Chicago Pritzker School of Medicine
    Angelle Desiree LaBeaud, MD, MS
    Stanford University School of Medicine
    Anne C.C. Lee, MD, MPH
    Brown University Medical School
    Katherine Phoenix Liao, MD, MPH
    Harvard Medical School, Brigham & Women’s Hospital
    Robbie G. Majzner, MD
    Harvard Medical School, Dana-Farber Cancer Institute
    Rajeev Malhotra, MD, MA
    Harvard Medical School, Massachusetts General Hospital
    Joseph D. Mancias, MD, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Nilam S. Mangalmurti, MD
    University of Pennsylvania Perelman School of Medicine
    Folasade P. May, MD, PhD, MPhil
    University of California, Los Angeles, David Geffen School of Medicine
    Megan E. McNerney, MD, PhD
    University of Chicago Pritzker School of Medicine
    Jaimie P. Meyer, MD, MS, FACP
    Yale School of Medicine
    Derek P. Narendra, MD, PhD
    National Institutes of Health
    Brian Timothy O’Neill, MD, PhD
    University of Iowa Carver College of Medicine
    Stephen T. Oh, MD, PhD
    Washington University School of Medicine in St. Louis
    Opeyemi A. Olabisi, MD, PhD
    Duke University School of Medicine
    Matthew G. Oser, MD, PHD
    Harvard Medical School, Dana-Farber Cancer Institute
    Eric Padron, MD
    Moffitt Cancer Center
    Akash Patnaik, MD, PhD, MMSc
    University of Chicago Pritzker School of Medicine
    Tien Peng, MD
    University of California, San Francisco, School of Medicine
    Paige M. Porrett, MD, PhD
    University of Alabama at Birmingham School of Medicine
    Camille E. Powe, MD
    Harvard Medical School, Massachusetts General Hospital
    David R. Raleigh, MD, PhD
    University of California, San Francisco, School of Medicine
    Deepak A. Rao, MD, PhD
    Harvard Medical School, Brigham & Women’s Hospital
    Meenakshi Rao, MD, PhD
    Harvard Medical School, Boston Children’s Hospital
    Abby Rachel Rosenberg, MD, MS, MA
    Harvard Medical School, Dana-Farber Cancer Institute
    Kathryn J. Ruddy, MD
    Mayo Clinic
    Elias Joseph Sayour, MD, PhD
    University of Florida College of Medicine
    Philip Oliver Scumpia, MD, PhD
    University of California, Los Angeles, David Geffen School of Medicine
    Chetan Seshadri, MD
    University of Washington School of Medicine
    Nilay Sethi, MD, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Nirali N. Shah, MD, MHSc
    NIH, National Cancer Institute (NCI)
    Keith Magnus Sigel, MD, PhD, MPH
    Icahn School of Medicine at Mount Sinai
    Emily K. Sims, MD
    Indiana University School of Medicine
    Zirui Song, MD, PhD
    Harvard Medical School, Massachusetts General Hospital
    Tomokazu Souma, MD, PhD
    Duke University School of Medicine
    Kathryn Elaine Stephenson, MD, MPH
    Harvard Medical School, Beth Israel Deaconess Medical Center
    Sean Robinson Stowell, MD, PhD
    Harvard Medical School, Brigham & Women’s Hospital
    Paul C. Tang, MD, PhD
    Mayo Clinic
    Justin Taylor, MD
    University of Miami Miller School of Medicine
    Marmar Vaseghi, MS, MD, PhD
    University of California, Los Angeles, David Geffen School of Medicine
    Elizabeth C. Verna, MD, MSc, FAASLD, FAST
    Columbia University Vagelos College of Physicians and Surgeons
    Srinivas Raghavan Viswanathan, MD, PhD
    Harvard Medical School, Dana-Farber Cancer Institute
    Daniel R. Wahl, MD, PhD
    University of Michigan Medical School
    Amisha Wallia, MD, MS
    Northwestern University Feinberg School of Medicine
    Taia T. Wang, MD, PhD
    Stanford University School of Medicine
    Marc Nathan Wein, MD, PhD
    Harvard Medical School, Massachusetts General Hospital
    Craig Brian Wilen, MD, PhD
    Yale School of Medicine
    Michael Robert Wilson, MD, MAS
    University of California, San Francisco, School of Medicine
    Graeme F. Woodworth, MD
    University of Maryland School of Medicine
    Kelley Yan, MD, PhD
    Columbia University Vagelos College of Physicians and Surgeons
    Dmitriy Zamarin, MD, PhD
    Icahn School of Medicine at Mount Sinai
    Lilei Zhang, MD, PhD
    Baylor College of Medicine

    Please join us in congratulating these newly elected members!

    Nominations open for 2025 Honorary membership

    The ASCI is pleased to call for nominations for 2025 Honorary membership. Nominees for this recognition must fit the criteria as given in the ASCI bylaws:

    Any distinguished person who has contributed significantly to the Society’s objectives, who has not been previously and unsuccessfully nominated for Active or International membership, and who enjoys an unimpeachable moral standing is eligible for nomination in this category.

    For the nominee who meets these criteria, there is no restriction on age or degree held.

    The deadline for receipt of nominations is February 17, 2025, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations and submits its recommendations to Active and Senior members for approval.

    The nominator must be an ASCI member in good standing and must start the nomination:

    • Access your member account
    • Go to the “Nominations” tab, then to the “Honorary membership nomination” section
    • Select “I’m the nominator” option
    • Search for your nominee:
      • If found, click on “Start nomination”
      • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Start nomination” for the newly created nominee in the “Results” section
    • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”
    • Provide a 250-word limit statement on the nominee’s qualifications
    • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed

    The nominee receives an email with information to access their part of the nomination and then must:

    • Provide a birth date and address information
    • Provide a brief (300-word limit) biography
    • Provide current institutional affiliation
    • Upload a full curriculum vitae
    • Complete a demographics survey
    • Identify research domain(s)
    • Submit this aspect of the nomination, which can be done regardless of whether the nominator or supporter has completed their statement